Eli Lilly Corp. buy UBS Group AG
Start price
02.02.26
/
50%
€891.90
Target price
02.02.27
-
Performance (%)
-12.13%
Price
17:49
€783.70
Summary
This prediction is currently active. The price of Eli Lilly Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.13%. This prediction currently runs until 02.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -6.062% | -6.062% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for LLY provided by MarketBeat
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€557.00
20.10.23
20.10.23
€670.67
20.10.24
20.10.24
51.40%
21.10.24
21.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24